Apotex announced the launch of its new premium value, Pharmacy Only range of vitamin and mineral supplements (VMS), Oviit today (July 3, 2017).
Expansion into this high growth VMS category signals further diversification of Apotex’s over-the-counter (OTC) portfolio, and a strategy for the generic drug manufacturer to restore value to the VMS category for pharmacy.
The initial Oviit range launches with a comprehensive, 34-product strong portfolio including formulations across such areas as general health, digestive health, immune health, cardiovascular health and skeletal health. This range is set to continue to grow and aims to offer a complete VMS solution for pharmacy.
Apotex Sales Director, Ben Sullivan, said, “This is a particularly competitive category, and pharmacy customers crave value for money. As a premium value, Pharmacy Only range, Oviit is pharmacy’s VMS solution to achieving maximum margins for high quality products in an expanding market, whilst building loyalty at the store level from a growing customer base.
“As more and more customers look to community pharmacy as their primary healthcare destination of choice, the Oviit range provides yet another solution from Apotex,” Mr Sullivan said.
Supported by Apotex’s strong national sales force, the Oviit range will be rolled out across pharmacies Australia-wide.
Apotex presently maintains a robust product portfolio across retail prescription, hospital, OTC and vitamins, minerals and supplements (VMS), a strong pipeline and focus on first-to-market launches, innovative and best-in-class professional services and training, and significant business partnerships across products and services.
Pharmacies wishing to access more information about the Oviit range of vitamins and mineral supplements can contact their Apotex Territory Manager.